1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsResearch Funding Opportunities (Various RFAs/PAs) is sponsored by National Cancer Institute (NCI). The National Cancer Institute (NCI) offers a broad portfolio of research funding opportunities through Requests for Applications (RFAs), Program Announcements (PAs), and trans-NIH initiatives supporting cancer research.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Use the NIH Grant search tool to find opportunities for NCI funding. To browse all NIH grant opportunities, clear the "NCI" preset filter. Explore NCI Research Priorities Review NCI Interest Areas and Highlighted Topics to learn about NCI priorities for cancer research and support.
Policy Notices and Updates NCI is partnering with Cancer Research UK to provide multiple rounds of funding for international, interdisciplinary teams to submit approaches addressing one of the open Cancer Grand Challenges. This page shares information on open opportunities and how to apply.
Early Stage Investigators who have submitted an R01 application within the NCI payline may be eligible for consideration for the Method to Extend Research in Time (MERIT) (R37) Award. Outstanding Investigator Award (R35) The Outstanding Investigator Award gives investigators the freedom to work on long-term projects with unusual potential in cancer research.
Research Specialist Award (R50) The R50 encourages the development of stable research career opportunities for exceptional scientists who want to continue to pursue research within the context of an existing NCI-funded basic, translational, clinical or population science cancer research program, but not serve as independent investigators.
Artificial Intelligence (AI) AI research is supported by a wide variety of grant and contract programs across NCI. Research projects in basic cancer biology are supported and coordinated through the Division of Cancer Biology (DCB). Behavioral research in cancer prevention and control is supported by the Division of Cancer Control and Population Sciences (DCCPS).
Biorepositories and Tissue Sample Collection Development of biospecimen-related policies and practices affecting NCI Biorepositories is coordinated and managed through the Biorepositories and Biospecimen Research Branch (BBRB).
Complementary and Alternative Medicine Research contributing to the advancement of evidence-based complementary and alternative medicine practice is supported by the Office of Cancer Complementary and Alternative Medicine (OCCAM). Epidemiology and Cancer Control Research in genetic, epidemiologic, behavioral, social, and surveillance cancer research is supported by the Division of Cancer Control and Population Sciences (DCCPS).
Research on HIV/AIDS pursued throughout the NCI, including programs in AIDS-related cancer are coordinated by the Office of HIV and AIDS Malignancy (OHAM). Research supporting the application of nanotechnology to all aspects of cancer research is supported by the NCI Alliance for Nanotechnology in Cancer program that is managed by the Office of Cancer Nanotechnology Research (OCNR).
Physical Sciences-Oncology Research supporting the establishment of scientific teams and individual scientists from the fields of physics, mathematics, chemistry, and engineering to develop novel approaches for cancer research is managed by the Physical Sciences in Oncology Initiative.
Research that determines and reduces a person’s risk of developing cancer, as well as research to develop and evaluate cancer screening procedures, is supported by the Division of Cancer Prevention (DCP). Research supporting the development of technologies and reagents that will advance our understanding of protein biology in cancer is supported by the Office of Cancer Clinical Proteomics Research (OCCPR).
Small Business and Small Business Technology Transfer Opportunities to increase small business and private sector participation to develop and commercialize novel technologies to prevent, diagnose, and treat cancer are managed by the Small Business Innovation Research and Small Business Technology Transfer (SBIR and STTR) programs.
Find current NCI and NIH opportunities for research supporting the development of technologies in laboratory and clinical cancer research. Research supporting the translation of promising research areas into improved diagnostic and therapeutic interventions for cancer patients is supported by the Division of Cancer Treatment and Diagnosis (DCTD).
According to the current listing, eligibility includes: Eligibility varies by specific RFA/PA, but generally includes non-profit organizations, institutions of higher education, and other research organizations. Confirm the full requirements in the official notice before applying.
Research Funding Opportunities (Various RFAs/PAs) is funded by National Cancer Institute (NCI). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
On May 21, 2026, the National Cancer Institute posted RFA-CA-27-006, RFA-CA-27-007, and RFA-CA-27-008 — the three competitive renewals for the NCI Community Oncology Research Program. Combined FY 2027 commitments reach $147.5 million across roughly 57 awards: $74.5 million for up to 7 Research Bases, $73 million for up to 50 Community and Academic Community Sites. Pre-application webinars run June 16-18 this week. Applications are due August 18, 2026 with six-year project periods. For community hospitals, oncology consortia, and NCI-designated cancer centers, this is the single largest cancer clinical-trials infrastructure decision NCI makes until 2033.
Read articleThe Breast Cancer Research Foundation launched a $100 million venture philanthropy fund at CGI on September 22, 2026, seeded with $23 million and aiming at 20 to 30 companies. Here is what the structure actually means for investigators, for startups in the valley of death, and for every disease foundation now weighing the same move.
Read articlePAR-27-062 creates a three-year, $80,000-salary postdoctoral career award across NCI, NIAID, NIBIB, NIDCR and NINDS — and it carries a hard eligibility window that closes two years after you start your postdoc. Full analysis of the Academic Career Excellence Award, what it replaces, and why the timing rule is the whole competition.
Read article